Skip to content

Effects of sub-anesthetic doses of esketamine on postoperative delirium and cognitive function in elderly thoracic surgery patients: a randomized, double-blind, placebo-active controlled noninferiority study

Effects of sub-anesthetic doses of esketamine on postoperative delirium and cognitive function in elderly thoracic surgery patients: a randomized, double-blind, placebo-active controlled noninferiority study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052750
Enrollment
Unknown
Registered
2021-11-05
Start date
2022-03-03
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Postive control group:Dexmedetomidine
Experimental group:Esketamine

Sponsors

Guangzhou Medical University Affiliated Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 60-90 years who underwent elective lung surgery or mediastinal esophagus surgery. Surgical types include: lung wedge resection, segmentectomy, lobectomy, sleeve lung resection, pneumonectomy, mediastinal tumor resection and diagnostic pleurectomy, radical esophagectomy, there are no restrictions on surgical methods (thoracotomy or VATS); 2. Surgery and general anesthesia time >= 2 hours, postoperative hospital stay at least 7 days; 3. No severe visual or auditory impairment, able to read text for neurobehavioral tests; 4. The patients participated voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. The score of the Simple Intelligence Scale Test (MMSE) is lower than 23; 2. Past history of dementia, mental illness or other central nervous system diseases; 3. Inability to understand Mandarin or Cantonese; 4. Those who are allergic to esketamine or dexmedetomidine; 5. Patients with intracranial hypertension, glaucoma and hyperthyroidism; 6. Patients with sick sinus syndrome, second-degree or higher atrioventricular block or sinus bradycardia (HR200/110mmHg); 11. ASA IV or V level.

Design outcomes

Primary

MeasureTime frame
postoperative delirium;

Secondary

MeasureTime frame
postoperative cognitive function;emergency delirium;pain numeric rating score;postoperative cognitive function;acetylcholine;brain derived neurotrophic factor (BDNF);

Countries

China

Contacts

Public ContactYao Yonghua

Guangzhou Medical University Affiliated Cancer Hospital

1575041594@qq.com+86 13711568864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026